{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:24:56Z","timestamp":1792016696621,"version":"4.4.0"},"reference-count":59,"publisher":"Japan Atherosclerosis Society","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2023,12,1]]},"DOI":"10.5551\/jat.rv22011","type":"journal-article","created":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T22:57:21Z","timestamp":1695855441000},"page":"1751-1758","source":"Crossref","is-referenced-by-count":23,"title":["The Impact of Ketone Body Metabolism on Mitochondrial Function and Cardiovascular Diseases"],"prefix":"10.5551","volume":"30","author":[{"given":"Yuichiro","family":"Arima","sequence":"first","affiliation":[{"name":"Developmental Cardiology Laboratory, International Research Center for Medical Science (IRCMS), Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Puchalska P, Crawford PA. Multi-dimensional Roles of Ketone Bodies in Fuel Metabolism, Signaling, and Therapeutics. Cell Metab, 2017; 25: 262-284","DOI":"10.1016\/j.cmet.2016.12.022"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Krebs HA. The regulation of the release of ketone bodies by the liver. Adv Enzym Regul, 1966; 4: 339-353","DOI":"10.1016\/0065-2571(66)90027-6"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Jr. GFC. Fuel Metabolism in Starvation. Annu Rev Nutr, 2006; 26: 1-22","DOI":"10.1146\/annurev.nutr.26.061505.111258"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Longo VD, Mattson MP. Fasting: Molecular Mechanisms and Clinical Applications. Cell Metab, 2014; 19: 181-192","DOI":"10.1016\/j.cmet.2013.12.008"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Maho YL, Kha HVV, Koubi H, Dewasmes G, Girard J, Ferre P, et al. Body composition, energy expenditure, and plasma metabolites in long-term fasting geese. Am J Physiol Metab, 1981; 241: E342-354","DOI":"10.1152\/ajpendo.1981.241.5.E342"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Arima Y, Nakagawa Y, Takeo T, Ishida T, Yamada T, Hino S, et al. Murine neonatal ketogenesis preserves mitochondrial energetics by preventing protein hyperacetylation. Nat Metab, 2021; 3: 196-210","DOI":"10.1038\/s42255-021-00342-6"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Araki E, Goto A, Kondo T, Noda M, Noto H, Origasa H, et al. Japanese Clinical Practice Guideline for Diabetes 2019. J Diabetes Investig, 2020; 11: 1020-1076","DOI":"10.1111\/jdi.13306"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Nasa P, Chaudhary S, Shrivastava PK, Singh A. Euglycemic diabetic ketoacidosis: A missed diagnosis. World J Diabetes, 2021; 12: 514-523","DOI":"10.4239\/wjd.v12.i5.514"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Varady KA, Cienfuegos S, Ezpeleta M, Gabel K. Clinical application of intermittent fasting for weight loss: progress and future directions. Nat Rev Endocrinol, 2022; 18: 309-321","DOI":"10.1038\/s41574-022-00638-x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Yurista SR, Chong CR, Badimon JJ, Kelly DP, Boer RA de, Westenbrink BD. Therapeutic Potential of Ketone Bodies for Patients With Cardiovascular Disease. J Am Coll Cardiol, 2021; 77: 1660-1669","DOI":"10.1016\/j.jacc.2020.12.065"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Longo VD, Anderson RM. Nutrition, longevity and disease: From molecular mechanisms to interventions. Cell, 2022; 185: 1455-1470","DOI":"10.1016\/j.cell.2022.04.002"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Fenselau A, Wallis K. 3-oxo acid coenzyme A-transferase in normal and diabetic rat muscle. Biochem J, 1976; 158: 509-512","DOI":"10.1042\/bj1580509"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Grinblat L, Bola\u00f1os LFP, Stoppani AO. Decreased rate of ketone-body oxidation and decreased activity of d -3-hydroxybutyrate dehydrogenase and succinyl-CoA: 3-oxo-acid CoA-transferase in heart mitochondria of diabetic rats. Biochem J, 1986; 240: 49-56","DOI":"10.1042\/bj2400049"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Mascaro C, Buesa C, Ortiz JA, Hare D, Hegardt FG. Molecular Cloning and Tissue Expression of Human Mitochondrial 3-Hydroxy-3-Methylglutaryl-CoA Synthase. Arch Biochem Biophys, 1995; 317: 385-390","DOI":"10.1006\/abbi.1995.1178"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) LEHNINGER AL, SUDDUTH HC, WISE JB. D-beta-Hydroxybutyric dehydrogenase of muitochondria. The J biological Chem, 1960; 235: 2450-2455","DOI":"10.1016\/S0021-9258(18)64641-1"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Williamson D, Lund P, Krebs H. The redox state of free nicotinamide-adenine dinucleotide in the cytoplasm and mitochondria of rat liver. Biochem J, 1967; 103: 514-527","DOI":"10.1042\/bj1030514"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) IWANAGA T, KISHIMOTO A. Cellular distributions of monocarboxylate transporters: a review. Biomed Res, 2015; 36: 279-301","DOI":"10.2220\/biomedres.36.279"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Hugo SE, Cruz-Garcia L, Karanth S, Anderson RM, Stainier DYR, Schlegel A. A monocarboxylate transporter required for hepatocyte secretion of ketone bodies during fasting. Genes Dev, 2012; 26: 282-293","DOI":"10.1101\/gad.180968.111"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) M. van HP, Sacha F, R. MG, P.N. RJ, Marjolein T, J. GM, et al. Monocarboxylate Transporter 1 Deficiency and Ketone Utilization. New Engl J Medicine, 2014; 371(20): 1900-1907","DOI":"10.1056\/NEJMoa1407778"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Matsuura TR, Puchalska P, Crawford PA, Kelly DP. Ketones and the Heart: Metabolic Principles and Therapeutic Implications. Circ Res, 2023; 132: 882-898","DOI":"10.1161\/CIRCRESAHA.123.321872"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Garc\u00eda-Rodr\u00edguez D, Gim\u00e9nez-Cassina A. Ketone Bodies in the Brain Beyond Fuel Metabolism: From Excitability to Gene Expression and Cell Signaling. Frontiers Mol Neurosci, 2021; 14: 732120","DOI":"10.3389\/fnmol.2021.732120"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Svensson K, Albert V, Cardel B, Salatino S, Handschin C. Skeletal muscle PGC-1\u03b1 modulates systemic ketone body homeostasis and ameliorates diabetic hyperketonemia in mice. FASEB J Off Publ Fed Am Soc Exp Biology, 2015; 30: 1976-1986","DOI":"10.1096\/fj.201500128"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Jr KCB, Snyder NW, Brandimarto J, Aziz M, Mesaros C, Worth AJ, et al. Evidence for Intramyocardial Disruption of Lipid Metabolism and Increased Myocardial Ketone Utilization in Advanced Human Heart Failure. Circulation, 2016; 133: 706-716","DOI":"10.1161\/CIRCULATIONAHA.115.017545"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Beylot M, Beaufr\u00e8re B, Normand S, Riou JP, Cohen R, Momex R. Determination of human ketone body kinetics using stable-isotope labelled tracers. Diabetologia, 1986; 29: 90-96","DOI":"10.1007\/BF00456116"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Ohba K, Sugiyama S, Sumida H, Nozaki T, Matsubara J, Matsuzawa Y, et al. Microvascular Coronary Artery Spasm Presents Distinctive Clinical Features With Endothelial Dysfunction as Nonobstructive Coronary Artery Disease. J Am Hear Assoc, 2012; 1: e002485","DOI":"10.1161\/JAHA.112.002485"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Arima Y, Izumiya Y, Ishida T, Takashio S, Ishii M, Sueta D, et al. Myocardial Ischemia Suppresses Ketone Body Utilization. J Am Coll Cardiol, 2019; 73: 246-247","DOI":"10.1016\/j.jacc.2018.10.040"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Mizuno Y, Harada E, Nakagawa H, Morikawa Y, Shono M, Kugimiya F, et al. The diabetic heart utilizes ketone bodies as an energy source. Metabolism, 2017; 77: 65-72","DOI":"10.1016\/j.metabol.2017.08.005"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Murashige D, Jang C, Neinast M, Edwards JJ, Cowan A, Hyman MC, et al. Comprehensive quantification of fuel use by the failing and nonfailing human heart. Science, 2020; 370: 364-368","DOI":"10.1126\/science.abc8861"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Lopaschuk GD, Ussher JR, Folmes CDL, Jaswal JS, Stanley WC. Myocardial Fatty Acid Metabolism in Health and Disease. Physiol Rev, 2010; 90: 207-258","DOI":"10.1152\/physrev.00015.2009"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Robinson AM, Williamson DH. Physiological roles of ketone bodies as substrates and signals in mammalian tissues. Physiol Rev, 1980; 60: 143-187","DOI":"10.1152\/physrev.1980.60.1.143"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Cheng CW, Biton M, Haber AL, Gunduz N, Eng G, Gaynor LT, et al. Ketone Body Signaling Mediates Intestinal Stem Cell Homeostasis and Adaptation to Diet. Cell, 2019; 178: 1115-1131.e15","DOI":"10.1016\/j.cell.2019.07.048"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Tomita I, Kume S, Sugahara S, Osawa N, Yamahara K, Yasuda-Yamahara M, et al. SGLT2 Inhibition Mediates Protection from Diabetic Kidney Disease by Promoting Ketone Body-Induced mTORC1 Inhibition. Cell Metab, 2020; 32: 404-419.e6","DOI":"10.1016\/j.cmet.2020.06.020"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Jebb D, Hiller M. Recurrent loss of HMGCS2 shows that ketogenesis is not essential for the evolution of large mammalian brains. eLife, 2018; 7: e38906","DOI":"10.7554\/eLife.38906"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Loomba R, Friedman SL, Shulman GI. Mechanisms and disease consequences of nonalcoholic fatty liver disease. Cell, 2021; 184: 2537-2564","DOI":"10.1016\/j.cell.2021.04.015"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Bragoszewski P, Habior A, Walewska-Zielecka B, Ostrowski J. Expression of genes encoding mitochondrial proteins can distinguish nonalcoholic steatosis from steatohepatitis. Acta biochimica Polonica, 2007; 54: 341-348","DOI":"10.18388\/abp.2007_3255"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) d\u2019Avignon DA, Puchalska P, Ercal B, Chang Y, Martin SE, Graham MJ, et al. Hepatic ketogenic insufficiency reprograms hepatic glycogen metabolism and the lipidome. JCI Insight, 2018; 3: e99762","DOI":"10.1172\/jci.insight.99762"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Cotter DG, Ercal B, Huang X, Leid JM, d\u2019Avignon DA, Graham MJ, et al. Ketogenesis prevents diet-induced fatty liver injury and hyperglycemia. J Clin Investig, 2014; 124: 5175-5190","DOI":"10.1172\/JCI76388"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Dorighello GG, Rovani JC, Paim BA, Rentz T, Assis LHP, Vercesi AE, et al. Mild Mitochondrial Uncoupling Decreases Experimental Atherosclerosis, A Proof of Concept. J Atheroscler Thromb, 2022; 29: 825-838","DOI":"10.5551\/jat.62796"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Asif S, Kim RY, Fatica T, Sim J, Zhao X, Oh Y, et al. Hmgcs2-mediated ketogenesis modulates high-fat diet-induced hepatosteatosis. Mol Metab, 2022; 61: 101494","DOI":"10.1016\/j.molmet.2022.101494"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Minciun\u0103 I, Gallage S, Heikenwalder M, Zelber-Sagi S, Dufour JF. Intermittent fasting- the future treatment in nash patients? Hepatology, 2023; Publish Ahead of Print","DOI":"10.1097\/HEP.0000000000000330"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Ezpeleta M, Gabel K, Cienfuegos S, Kalam F, Lin S, Pavlou V, et al. Effect of alternate day fasting combined with aerobic exercise on non-alcoholic fatty liver disease: A randomized controlled trial. Cell Metab, 2023; 35: 56-70.e3","DOI":"10.1016\/j.cmet.2022.12.001"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Lommi J, Kupari M, Koskinen P, N\u00e4veri H, Leinonen H, Pulkki K, et al. Blood ketone bodies in congestive heart failure. J Am Coll Cardiol, 1996; 28: 665-672","DOI":"10.1016\/0735-1097(96)00214-8"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Aubert G, Martin OJ, Horton JL, Lai L, Vega RB, Leone TC, et al. The Failing Heart Relies on Ketone Bodies as a Fuel. Circulation, 2016; 133: 698-705","DOI":"10.1161\/CIRCULATIONAHA.115.017355"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Schugar RC, Moll AR, d\u2019Avignon DA, Weinheimer CJ, Kovacs A, Crawford PA. Cardiomyocyte-specific deficiency of ketone body metabolism promotes accelerated pathological remodeling. Mol Metab, 2014; 3: 754-769","DOI":"10.1016\/j.molmet.2014.07.010"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Uchihashi M, Hoshino A, Okawa Y, Ariyoshi M, Kaimoto S, Tateishi S, et al. Cardiac-Specific Bdh1 Overexpression Ameliorates Oxidative Stress and Cardiac Remodeling in Pressure Overload\u2013Induced Heart Failure. Circ Hear Fail, 2017; 10: e004417","DOI":"10.1161\/CIRCHEARTFAILURE.117.004417"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) Horton JL, Davidson MT, Kurishima C, Vega RB, Powers JC, Matsuura TR, et al. The failing heart utilizes 3-hydroxybutyrate as a metabolic stress defense. JCI Insight, 2019; 4","DOI":"10.1172\/jci.insight.124079"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47) Deng Y, Xie M, Li Q, Xu X, Ou W, Zhang Y, et al. Targeting Mitochondria-Inflammation Circuit by \u03b2-Hydroxybutyrate Mitigates HFpEF. Circ Res, 2021; 128: 232-245","DOI":"10.1161\/CIRCRESAHA.120.317933"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48) Nielsen R, M\u00f8ller N, Gormsen LC, Tolbod LP, Hansson NH, Sorensen J, et al. Cardiovascular Effects of Treatment With the Ketone Body 3-Hydroxybutyrate in Chronic Heart Failure Patients. Circulation, 2019; 139: 2129-2141","DOI":"10.1161\/CIRCULATIONAHA.118.036459"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49) Ho KL, Zhang L, Wagg C, Batran RA, Gopal K, Levasseur J, et al. Increased ketone body oxidation provides additional energy for the failing heart without improving cardiac efficiency. Cardiovasc Res, 2019; 115: cvz045","DOI":"10.1093\/cvr\/cvz045"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50) Takahara S, Soni S, Maayah ZH, Ferdaoussi M, Dyck JRB. Ketone therapy for heart failure: current evidence for clinical use. Cardiovasc Res, 2021; 118: 977-987","DOI":"10.1093\/cvr\/cvab068"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51) Takahara S, Soni S, Phaterpekar K, Kim TT, Maayah ZH, Levasseur JL, et al. Chronic exogenous ketone supplementation blunts the decline of cardiac function in the failing heart. ESC Hear Fail, 2021; 8: 5606-5612","DOI":"10.1002\/ehf2.13634"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52) Zou Z, Sasaguri S, Rajesh KG, Suzuki R. dl-3-Hydroxybutyrate administration prevents myocardial damage after coronary occlusion in rat hearts. Am J Physiol Circ Physiol, 2002; 283: H1968-1974","DOI":"10.1152\/ajpheart.00250.2002"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53) Santos-Gallego CG, Requena-Ib\u00e1\u00f1ez JA, Picatoste B, Fardman B, Ishikawa K, Mazurek R, et al. Cardioprotective Effect of Empagliflozin and Circulating Ketone Bodies During Acute Myocardial Infarction. Circ Cardiovasc Imaging, 2023; 16: e015298","DOI":"10.1161\/CIRCIMAGING.123.015298"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54) L\u00f3pez-Ot\u00edn C, Blasco MA, Partridge L, Serrano M, Kroemer G. Hallmarks of aging: An expanding universe. Cell, 2023; 186: 243-278","DOI":"10.1016\/j.cell.2022.11.001"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55) Longo VD, Panda S. Fasting, Circadian Rhythms, and Time-Restricted Feeding in Healthy Lifespan. Cell Metab, 2016; 23: 1048-1059","DOI":"10.1016\/j.cmet.2016.06.001"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56) Roberts MN, Wallace MA, Tomilov AA, Zhou Z, Marcotte GR, Tran D, et al. A Ketogenic Diet Extends Longevity and Healthspan in Adult Mice. Cell Metab, 2017; 26: 539-546.e5","DOI":"10.1016\/j.cmet.2017.08.005"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57) Newman JC, Covarrubias AJ, Zhao M, Yu X, Gut P, Ng CP, et al. Ketogenic Diet Reduces Midlife Mortality and Improves Memory in Aging Mice. Cell Metab, 2017; 26: 547-557.e8","DOI":"10.1016\/j.cmet.2017.08.004"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58) Tomita I, Tsuruta H, Yasuda\u2010Yamahara M, Yamahara K, Kuwagata S, Tanaka\u2010Sasaki Y, et al. Ketone bodies: A double\u2010edged sword for mammalian life span. Aging Cell, 2023; e13833","DOI":"10.1111\/acel.13833"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59) Pan C, Herrero-Fernandez B, Almarcha CB, Bris RG, Zorita V, S\u00e1ez A, et al. Time-Restricted Feeding Enhances Early Atherosclerosis in Hypercholesterolemic Mice. Circulation, 2023; 147: 774-777","DOI":"10.1161\/CIRCULATIONAHA.122.063184"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/30\/12\/30_RV22011\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,2]],"date-time":"2023-12-02T04:37:10Z","timestamp":1701491830000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/30\/12\/30_RV22011\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,1]]},"references-count":59,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.rv22011","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,1]]},"article-number":"RV22011"}}